1.
|
Phase: Phase IV Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: EU-HNBE-2003, NCT00198263
|
|
2.
|
Phase: Phase IV Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: EU-CCBE-2003, NCT00198276
|
|
3.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: 16 to 50 Sponsor: Other Protocol IDs: EORTC-30983, NCT00003643
|
|
4.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: DFCI-75100
|
|
5.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: under 65 Sponsor: Protocol IDs: WCCC-CO-7711R, NCI-D80-048-183
|
|
6.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: SWOG-8107
|
|
7.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: 25 to 65 Sponsor: Protocol IDs: DFCI-75116
|
|
8.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: SEG-GU-306
|
|
9.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: DFCI-83084, NCI-T84-0282D, T84-0282
|
|
10.
|
Phase: Phase III Type: Treatment Status: Completed Age: any age Sponsor: NCI Protocol IDs: GOG-149, GOG-0149
|
|
11.
|
Phase: Phase III Type: Treatment Status: Closed Age: 50 and over Sponsor: Protocol IDs: EORTC-20932
|
|
12.
|
Phase: Phase III Type: Treatment Status: Closed Age: 15 to 69 Sponsor: Protocol IDs: CRC-TU-HO3001, EU-93029
|
|
13.
|
Phase: Phase III Type: Treatment Status: Completed Age: over 15 Sponsor: NCI, Other Protocol IDs: CDR0000063574, MDA-DM-94017, NCI-T94-0040D, T94-0040, NCT00002565
|
|
14.
|
Phase: Phase III Type: Treatment Status: Closed Age: under 75 Sponsor: Protocol IDs: FRE-FNCLCC-CO-II, NCI-F94-0020
|
|
15.
|
Phase: Phase III Type: Treatment Status: Closed Age: 16 to 70 Sponsor: Protocol IDs: MRC-TE03, EU-94027
|
|
16.
|
Phase: Phase III Type: Treatment Status: Completed Age: 12 and over Sponsor: NCI Protocol IDs: MSKCC-94076, CLB-99812, E-3894, SWOG-9442, NCI-T94-0086D, NCT00002596, T94-0086
|
|
17.
|
Phase: Phase III Type: Treatment Status: Closed Age: under 21 at diagnosis Sponsor: NCI Protocol IDs: CCG-5942
|
|
18.
|
Phase: Phase III Type: Treatment Status: Closed Age: under 65 Sponsor: Protocol IDs: EORTC-30941, MRC-TE20, EU-95004
|
|
19.
|
Phase: Phase III Type: Treatment Status: Completed Age: no age specified Sponsor: Protocol IDs: MSKCC-75104
|
|
20.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 21 and under Sponsor: NCI Protocol IDs: POG-9426, CCG-P9426, NCT00002827
|
|
21.
|
Phase: Phase III Type: Treatment Status: Completed Age: 15 to 59 Sponsor: NCI, Other Protocol IDs: MDA DM95-121, P30CA016672, NCI-V96-1010, CDR0000065044, NCT00002835
|
|
22.
|
Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: E-8592, NCCTG-942853, NCI-P96-0076, NCT00002872
|
|
23.
|
Phase: Phase III Type: Treatment Status: Closed Age: 15 to 70 Sponsor: Protocol IDs: FRE-FNCLCC-T93BP, FRE-T93BP, EU-96016
|
|
24.
|
Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 21 and under Sponsor: NCI Protocol IDs: COG-9425, NCT00005578, POG-9425
|
|
25.
|
Phase: Phase III Type: Treatment Status: Closed Age: 16 to 75 Sponsor: Protocol IDs: MRC-UKLG-LY07, EU-97004, NCT00002987
|